These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21681413)

  • 1. Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system.
    Cho MC; Lee DH; Kim EJ; Lee JY; Kang JW; Song JH; Chong Y; Kim Y; Hong JT; Yoon DY
    Mol Cell Biochem; 2011 Dec; 358(1-2):75-83. PubMed ID: 21681413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma.
    Atanasov AG; Blunder M; Fakhrudin N; Liu X; Noha SM; Malainer C; Kramer MP; Cocic A; Kunert O; Schinkovitz A; Heiss EH; Schuster D; Dirsch VM; Bauer R
    PLoS One; 2013; 8(4):e61755. PubMed ID: 23630612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
    Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
    Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-(3,5-Di-tert-butyl-4-hydroxybenzylidene) thiazolidine-2,4-dione modulates peroxisome proliferators-activated receptor gamma in 3T3-L1 adipocytes: roles as a PPARgamma ligand.
    Cho MC; Lee WS; Hong JT; Park SW; Moon DC; Paik SG; Yoon DY
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):96-102. PubMed ID: 16171942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists.
    Kaserer T; Obermoser V; Weninger A; Gust R; Schuster D
    Eur J Med Chem; 2016 Nov; 124():49-62. PubMed ID: 27560282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation.
    Guasch L; Sala E; Castell-Auví A; Cedó L; Liedl KR; Wolber G; Muehlbacher M; Mulero M; Pinent M; Ardévol A; Valls C; Pujadas G; Garcia-Vallvé S
    PLoS One; 2012; 7(11):e50816. PubMed ID: 23226391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds.
    Porskjær Christensen L; Bahij El-Houri R
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30248999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple ELISA for screening ligands of peroxisome proliferator-activated receptor-gamma.
    Cho MC; Lee HS; Kim JH; Choe YK; Hong JT; Paik SG; Yoon DY
    J Biochem Mol Biol; 2003 Mar; 36(2):207-13. PubMed ID: 12689521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.
    Bhalla K; Hwang BJ; Choi JH; Dewi R; Ou L; Mclenithan J; Twaddel W; Pozharski E; Stock J; Girnun GD
    J Biol Chem; 2011 Dec; 286(48):41626-41635. PubMed ID: 21979952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells.
    Thompson GM; Trainor D; Biswas C; LaCerte C; Berger JP; Kelly LJ
    Anal Biochem; 2004 Jul; 330(1):21-8. PubMed ID: 15183757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol: a non-adipogenic PPARγ agonist from nature.
    Atanasov AG; Wang JN; Gu SP; Bu J; Kramer MP; Baumgartner L; Fakhrudin N; Ladurner A; Malainer C; Vuorinen A; Noha SM; Schwaiger S; Rollinger JM; Schuster D; Stuppner H; Dirsch VM; Heiss EH
    Biochim Biophys Acta; 2013 Oct; 1830(10):4813-9. PubMed ID: 23811337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.
    Amato AA; Rajagopalan S; Lin JZ; Carvalho BM; Figueira AC; Lu J; Ayers SD; Mottin M; Silveira RL; Souza PC; Mourão RH; Saad MJ; Togashi M; Simeoni LA; Abdalla DS; Skaf MS; Polikparpov I; Lima MC; Galdino SL; Brennan RG; Baxter JD; Pitta IR; Webb P; Phillips KJ; Neves FA
    J Biol Chem; 2012 Aug; 287(33):28169-79. PubMed ID: 22584573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
    Rival Y; Stennevin A; Puech L; Rouquette A; Cathala C; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Wurch T; Junquéro D
    J Pharmacol Exp Ther; 2004 Nov; 311(2):467-75. PubMed ID: 15273253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional coactivator EDF-1 is required for PPARgamma-stimulated adipogenesis.
    Leidi M; Mariotti M; Maier JA
    Cell Mol Life Sci; 2009 Aug; 66(16):2733-42. PubMed ID: 19554257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice.
    Huan Y; Pan X; Peng J; Jia C; Sun S; Bai G; Wang X; Zhou T; Li R; Liu S; Li C; Liu Q; Liu Z; Shen Z
    Diabetes Obes Metab; 2019 Nov; 21(11):2553-2563. PubMed ID: 31364797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
    Fang XK; Gao J; Zhu DN
    Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA
    Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA; Cvoro A; Amato AA; Sieglaff DH; Filgueira CS; Arumanayagam AS; de Lima Mdo C; Pitta IR; de Assis Rocha Neves F; Webb P
    Biochem Biophys Res Commun; 2015 Aug; 464(3):718-23. PubMed ID: 26168725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
    J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.